Foot-and-Mouth Disease Virus Lacking the Leader Protein and Containing Two Negative DIVA Markers (FMDV LL3B3D A<sub>24</sub>) Is Highly Attenuated in Pigs
Inactivated whole-virus vaccines are widely used for the control of foot-and-mouth disease (FMD). Their production requires the growth of large quantities of virulent FMD virus in biocontainment facilities, which is expensive and carries the risk of an inadvertent release of virus. Attenuated recomb...
المؤلفون الرئيسيون: | Michael Eschbaumer, Veronika Dill, Jolene C. Carlson, Jonathan Arzt, Carolina Stenfeldt, Peter W. Krug, John M. Hardham, Jacob E. Stegner, Luis L. Rodriguez, Elizabeth Rieder |
---|---|
التنسيق: | مقال |
اللغة: | English |
منشور في: |
MDPI AG
2020-02-01
|
سلاسل: | Pathogens |
الموضوعات: | |
الوصول للمادة أونلاين: | https://www.mdpi.com/2076-0817/9/2/129 |
مواد مشابهة
-
Novel Foot-and-Mouth Disease Vaccine Platform: Formulations for Safe and DIVA-Compatible FMD Vaccines With Improved Potency
حسب: John M. Hardham, وآخرون
منشور في: (2020-09-01) -
Exchange of C-Terminal Variable Sequences within Morbillivirus Nucleocapsid Protein Are Tolerated: Development and Evaluation of Two Marker (DIVA) Vaccines (Sungri/96 DIVA, Nigeria/75/1 DIVA) against PPR
حسب: Muneeswaran Selvaraj, وآخرون
منشور في: (2021-11-01) -
The Safety and Efficacy of New DIVA Inactivated Vaccines Against Lumpy Skin Disease in Calves
حسب: Gaetano Federico Ronchi, وآخرون
منشور في: (2024-11-01) -
Assessing the Protective Dose of a Candidate DIVA Vaccine against Classical Swine Fever
حسب: Tinka Jelsma, وآخرون
منشور في: (2021-05-01) -
Serological Hendra Virus Diagnostics Using an Indirect ELISA-Based DIVA Approach with Recombinant Hendra G and N Proteins
حسب: Anne Balkema-Buschmann, وآخرون
منشور في: (2022-05-01)